A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Conditions
Alopecia Areata
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Center For Dermatology Clinical Research, Inc., Fremont, California, United States
Contact: Principal Investigator (Sunil Dhawan)Northridge Clinical Trials, Northridge, California, United States
Contact: Principal Investigator (Navid Ezra)Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway, Santa Clarita, California, United States
Contact: Principal Investigator (Bernard Raskin)Health Clinical Research, LLC, Cutler Bay, Florida, United States
Contact: Principal Investigator (Soroush Aghigh)Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Arash Mostaghimi)Revival Research Institute, LLC, Troy, Michigan, United States
Contact: Principal Investigator (Ali Moiin)Stracskin, Portsmouth, New Hampshire, United States
Contact: Principal Investigator (Abel Jarell)Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue, San Antonio, Texas, United States
Contact: Principal Investigator (John Browning)Jordan Valley Dermatology & Research Center, South Jordan, Utah, United States
Contact: Principal Investigator (Douglass Forsha)Kelowna Health and Memory Centre, Kelowna, Canada
Contact: Principal Investigator (Nicola Gray)Ryan Clinical Research Inc., Newmarket, Canada
Contact: Principal Investigator (Sanjay Siddha)Dar Clinical Research - Ottawa - Hunt Club Road, Ottawa, Canada
Contact: Principal Investigator (Reetesh Bose)SIMa Recherche, Verdun, Canada
Contact: Principal Investigator (Simon Nigen)Beijing Friendship Hospital Affiliate of Capital University, Beijing, China
Contact: Principal Investigator (Fenglin Zhuo)Huashan Hospital, Fudan University, Shanghai, China
Contact: Principal Investigator (Wenyu Wu)Shanghai Skin Disease Hospital, Shanghai, China
Contact: Principal Investigator (Yuling Shi)Tianjin Medical University General Hospital, Tianjin, China
Contact: Principal Investigator (Huiping Wang)Erasmus Medisch Centrum, Rotterdam, Netherlands
Contact: Principal Investigator (Rick Waalboer-Spuij)Centrum Badan Klinicznych PI-House sp. z o.o., Gdansk, Poland
Contact: Principal Investigator (Aleksandra Okuniewska)Diamond Clinic, Krakow, Poland
Contact: Principal Investigator (Barbara Rewerska)Dermedic Jacek Zdybski, Ostrowiec Świętokrzyski, Poland
Contact: Principal Investigator (Jacek Zdybski)Centrum Medyczne Ginemedica, Wroclaw, Poland
Contact: Principal Investigator (Justyna Kwapisz)Chung-Ang University Hospital, Dongjak-gu, South Korea
Contact: Principal Investigator (Beomjoon Kim)Inha University Hospital, Incheon, South Korea
Contact: Principal Investigator (Gwang Seong Choi)Jeonbuk National University Hospital, Jeonju, South Korea
Contact: Principal Investigator (Jin Park)Seoul National University Hospital, Seoul, South Korea
Contact: Principal Investigator (OHSANG KWON)Kyung Hee University Hospital at Gangdong, Seoul, South Korea
Contact: Principal Investigator (Bark Lynn Lew)Royal London Hospital, London, United Kingdom
Contact: Principal Investigator (Maria Angeliki Gkini)Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom
Contact: Principal Investigator (Leila Asfour)Salford Royal Hospital, Salford, United Kingdom
Contact: Principal Investigator (Matthew Harries)
Study leads
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company